Scottish Investment Bank has supported a funding round for Causeway Therapeutics, a spinout from University of Glasgow that is working on treatments for tendon injuries and disorders.

Causeway Therapeutics, a UK-based developer of therapies for tendinopathies, collected £1m ($1.3m) in funding yesterday from investors including Scottish Investment Bank, the investment arm of state-owned economic development agency Scottish Enterprise.

Biotech-focused investment firm Mediqventure also participated in the round.

Causeway Therapeutics is working on Tenomir, a treatment for tendinopathies in humans. Tendinopathies are tendon injuries and disorders that commonly account for 30% to 50% of sporting injuries, and affect about 1 in 10 people through repetitive strain or major…